Claim debt
The product promise is not translated into controlled regulatory and design logic early enough.
From early claim logic to a traceable development and documentation structure.
Many MedTech startups build first and document later. That feels fast in the beginning, but it creates regulatory debt: unclear claims, scattered decisions, missing records and late verification logic.
The product promise is not translated into controlled regulatory and design logic early enough.
Development decisions, risks, tests, reviews and approvals are scattered across tools, people and folders.
Technical documentation becomes a rescue project instead of the visible result of controlled development.
Evidence created during development proves how the product was built, controlled and reviewed.
Before teams write technical documentation, they need to understand what the product is allowed to claim, for whom and in which use context.
The claim affects intended use, route assumptions, design input, risk management, verification planning, clinical evidence and later technical documentation. If the claim is weak or unstable, the whole documentation structure becomes unstable.
Clarify what the product promises before documentation debt starts.
Clarify what the product promises, who it is for, where it is used and which performance, safety or clinical claims follow from that.
Evidence is not added after development. It is designed into the way the team works.
QMS-connected evidenceEasy13485 does not treat engineering and documentation as separate worlds. The capability helps teams structure development work so that key decisions, risks, tests, reviews and approvals become usable evidence.
Why was a design direction chosen, changed or rejected?
Which hazards, risks and controls are connected to the design and intended use?
How will the team show that requirements have been met?
How will the team show that the product works for intended users and use context?
How do claims, requirements, risks, tests, records and documents connect?
It is the visible link between product decisions and regulatory evidence.
Easy13485 connects technical documentation to the QMS operating model. Evidence is created through roles, processes, templates, reviews, approvals, records and training logic.
That is what separates the Makerspace approach from document generators, gap-check tools or late-stage documentation rescue.
Evidence & Technical Documentation supports every stage where product development must become controlled, reviewable and traceable.
Clarifies the claim, intended use, route assumptions and documentation risk before the team commits to unnecessary QMS depth.
Translates early product direction into PLC planning, first design input and evidence strategy.
Turns development work into controlled records, traceability, verification logic, Medical Device File structure and technical documentation.
Uses Easy Expert to make the Easy13485 structure easier to navigate and reuse.
Keeps documentation, records, roles, PMS, CAPA, training evidence and management review connected during QMS operation.
The point is not to produce more documents. The point is to make product decisions, evidence, reviews and records easier to understand, maintain and use as the product matures.
Claim, intended use and route assumptions are translated into a structure the team can work with.
Design input, risk logic, verification, validation and records grow together with the product.
The Medical Device File and technical documentation are built from controlled evidence instead of being reconstructed later.
Start with Claim Check before technical documentation becomes regulatory debt.
